Neogen's (NEOG) Soleris For EBAC Receives AOAC's Clearance
Zacks Investment Research | Dec 19, 2019 10:08PM ET
Neogen Corporation (NASDAQ:NEOG) announced the receipt of approval from the AOAC Research Institute for its Soleris for Enterobacteriaceae (EBAC). The test has been designed for the prevention of bacterial contamination of food, pet food, nutraceutical, pharmaceutical and cosmetic products.
Per Neogen, the Soleris test, which provides rapid and accurate results, is poised to further improve the company’s profitability by strengthening its customer base. The Soleris is one of the company’s tests for spoilage microorganisms, which is part of the Food Safety segment.
Notably, the Soleris test was developed by Centrus International, which Neogen acquired in 2006.
With the approval, Neogen aims to strengthen its Food Safety segment globally.
Solaris for EBAC at a Glance
With the AOAC's Performance Tested Method Certification, the Soleris for EBAC test received independent validation of its ability to precisely detect EBAC in a wide variety of sample types.
Significance of the Approval
The Soleris test is less time consuming as it is an automated and rapid optical system for the detection of microbial contamination. This marks an improvement over the traditional methods.
Additionally, Soleris for EBAC was certified by MicroVal — an international certification organization for the validation and approval of alternative (confirmation) methods for the microbiological analysis of food, beverages and water. The certification proves that a proprietary method is on par with the reference method as far as performance is concerned.
Industry Prospects
Per a report by Zacks Investment Research
Get The News You Want
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.